Skip to main content
Top
Published in: Diabetologia 4/2008

01-04-2008 | Article

Proliferative retinopathy and proteinuria predict mortality rate in type 1 diabetic patients from Fyn County, Denmark

Authors: J. Grauslund, A. Green, A. K. Sjølie

Published in: Diabetologia | Issue 4/2008

Login to get access

Abstract

Aims/hypothesis

We evaluated the effect of diabetic retinopathy on 25 year survival rate among a population-based cohort of type 1 diabetic patients from Fyn County, Denmark.

Methods

In 1973 all diabetic patients from Fyn County, Denmark with onset before the age of 30 years as of 1 July 1973 were identified (n = 727). In 1981, only 627 patients were still alive and resident in Denmark. Of these, 573 (91%) participated in a clinical baseline examination, in which diabetic retinopathy was graded and other markers of diabetes measured. Mortality rate was examined in a 25 year follow-up and related to the baseline examination.

Results

Of the 573 patients examined at baseline in 1981 and 1982, 297 (51.8%) were still alive in November 2006. Of the others, 256 (44.7%) had died, three (0.5%) had left Denmark and 17 (3%) were of unknown status. Age- and sex-adjusted HRs of mortality rate were 1.01 (95% CI 0.72–1.42) and 2.04 (1.43–2.91) for patients with non-proliferative and proliferative retinopathy respectively at baseline compared with patients with no retinopathy. After adjusting for proteinuria, HR among patients with proliferative retinopathy lost statistical significance, but still remained 1.48 (95% CI 0.98–2.23). The 10 year survival rate of patients who had proliferative retinopathy as well as proteinuria at baseline was 22.2% and significantly lower (p < 0.001) than in patients with proteinuria only (70.3%), proliferative retinopathy only (79.0%) or neither (86.6%).

Conclusions/interpretation

Proliferative retinopathy and proteinuria predict mortality rate in a population-based cohort of type 1 diabetic patients. In combination they act even more strongly. Non-proliferative diabetic retinopathy did not affect survival rate.
Literature
1.
go back to reference Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM (2006) All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia 49:660–666PubMedCrossRef Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM (2006) All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992–1999. Diabetologia 49:660–666PubMedCrossRef
2.
go back to reference Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H (2001) Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44(Suppl 2):S14–S21PubMedCrossRef Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H (2001) Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44(Suppl 2):S14–S21PubMedCrossRef
3.
go back to reference Asao K, Sarti C, Forsen T et al (2003) Long-term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland. Diabetes Care 26:2037–2042PubMedCrossRef Asao K, Sarti C, Forsen T et al (2003) Long-term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland. Diabetes Care 26:2037–2042PubMedCrossRef
4.
go back to reference Laing SP, Swerdlow AJ, Slater SD et al (1999) The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med 16:459–465PubMedCrossRef Laing SP, Swerdlow AJ, Slater SD et al (1999) The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med 16:459–465PubMedCrossRef
5.
go back to reference Dorman JS, LaPorte RE, Kuller LH et al (1984) The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes 33:271–276PubMedCrossRef Dorman JS, LaPorte RE, Kuller LH et al (1984) The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes 33:271–276PubMedCrossRef
6.
go back to reference Klein R, Klein BE, Moss SE, Cruickshanks KJ (1999) Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 117:1487–1495PubMed Klein R, Klein BE, Moss SE, Cruickshanks KJ (1999) Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol 117:1487–1495PubMed
7.
go back to reference Rajala U, Pajunpaa H, Koskela P, Keinanen-Kiukaanniemi S (2000) High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy. Diabetes Care 23:957–961PubMedCrossRef Rajala U, Pajunpaa H, Koskela P, Keinanen-Kiukaanniemi S (2000) High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy. Diabetes Care 23:957–961PubMedCrossRef
8.
go back to reference Wong JS, Pearson DW, Murchison LE, Williams MJ, Narayan V (1991) Mortality in diabetes mellitus: experience of a geographically defined population. Diabet Med 8:135–139PubMed Wong JS, Pearson DW, Murchison LE, Williams MJ, Narayan V (1991) Mortality in diabetes mellitus: experience of a geographically defined population. Diabet Med 8:135–139PubMed
9.
go back to reference Waugh NR, Dallas JH, Jung RT, Newton RW (1989) Mortality in a cohort of diabetic patients. Causes and relative risks. Diabetologia 32:103–104PubMedCrossRef Waugh NR, Dallas JH, Jung RT, Newton RW (1989) Mortality in a cohort of diabetic patients. Causes and relative risks. Diabetologia 32:103–104PubMedCrossRef
10.
go back to reference Henricsson M, Nilsson A, Heijl A, Janzon L, Groop L (1997) Mortality in diabetic patients participating in an ophthalmological control and screening programme. Diabet Med 14:576–583PubMedCrossRef Henricsson M, Nilsson A, Heijl A, Janzon L, Groop L (1997) Mortality in diabetic patients participating in an ophthalmological control and screening programme. Diabet Med 14:576–583PubMedCrossRef
11.
go back to reference van Hecke MV, Dekker JM, Stehouwer CD et al (2005) Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care 28:1383–1389PubMedCrossRef van Hecke MV, Dekker JM, Stehouwer CD et al (2005) Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care 28:1383–1389PubMedCrossRef
12.
go back to reference Klein BE, Klein R, McBride PE et al (2004) Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 164:1917–1924PubMedCrossRef Klein BE, Klein R, McBride PE et al (2004) Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 164:1917–1924PubMedCrossRef
13.
go back to reference Klein R, Moss SE, Klein BE, DeMets DL (1989) Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med 149:266–272PubMedCrossRef Klein R, Moss SE, Klein BE, DeMets DL (1989) Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med 149:266–272PubMedCrossRef
14.
go back to reference Cusick M, Meleth AD, Agron E et al (2005) Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27. Diabetes Care 28:617–625PubMedCrossRef Cusick M, Meleth AD, Agron E et al (2005) Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27. Diabetes Care 28:617–625PubMedCrossRef
15.
go back to reference Walters DP, Gatling W, Houston AC, Mullee MA, Julious SA, Hill RD (1994) Mortality in diabetic subjects: an eleven-year follow-up of a community-based population. Diabet Med 11:968–973PubMedCrossRef Walters DP, Gatling W, Houston AC, Mullee MA, Julious SA, Hill RD (1994) Mortality in diabetic subjects: an eleven-year follow-up of a community-based population. Diabet Med 11:968–973PubMedCrossRef
16.
go back to reference Davis MD, Hiller R, Magli YL et al (1979) Prognosis for life in patients with diabetes: relation to severity of retinopathy. Trans Am Ophthalmol Soc 77:144–170PubMed Davis MD, Hiller R, Magli YL et al (1979) Prognosis for life in patients with diabetes: relation to severity of retinopathy. Trans Am Ophthalmol Soc 77:144–170PubMed
17.
go back to reference Roy M, Rendas-Baum R, Skurnick J (2006) Mortality in African-Americans with type 1 diabetes: The New Jersey 725. Diabet Med 23:698–706PubMedCrossRef Roy M, Rendas-Baum R, Skurnick J (2006) Mortality in African-Americans with type 1 diabetes: The New Jersey 725. Diabet Med 23:698–706PubMedCrossRef
18.
go back to reference Green A, Hauge M, Holm NV, Rasch LL (1981) Epidemiological studies of diabetes mellitus in Denmark. II. A prevalence study based on insulin prescriptions. Diabetologia 20:468–470PubMedCrossRef Green A, Hauge M, Holm NV, Rasch LL (1981) Epidemiological studies of diabetes mellitus in Denmark. II. A prevalence study based on insulin prescriptions. Diabetologia 20:468–470PubMedCrossRef
19.
go back to reference Sjolie AK (1985) Ocular complications in insulin treated diabetes mellitus. An epidemiological study. Acta Ophthalmol Suppl 172:1–77PubMed Sjolie AK (1985) Ocular complications in insulin treated diabetes mellitus. An epidemiological study. Acta Ophthalmol Suppl 172:1–77PubMed
20.
go back to reference Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520–526PubMed Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520–526PubMed
21.
go back to reference Orchard TJ, Dorman JS, Maser RE et al (1990) Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39:1116–1124PubMedCrossRef Orchard TJ, Dorman JS, Maser RE et al (1990) Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39:1116–1124PubMedCrossRef
22.
go back to reference No authors listed (1994) Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37:278–285CrossRef No authors listed (1994) Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37:278–285CrossRef
23.
go back to reference Lin DY, Blumenkranz MS, Brothers RJ, Grosvenor DM (2002) The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol 134:204–213PubMedCrossRef Lin DY, Blumenkranz MS, Brothers RJ, Grosvenor DM (2002) The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol 134:204–213PubMedCrossRef
24.
go back to reference Klein R, Klein BE, Moss SE (1991) The incidence of gross proteinuria in people with insulin-dependent diabetes mellitus. Arch Intern Med 151:1344–1348PubMedCrossRef Klein R, Klein BE, Moss SE (1991) The incidence of gross proteinuria in people with insulin-dependent diabetes mellitus. Arch Intern Med 151:1344–1348PubMedCrossRef
25.
go back to reference Ono T, Kobayashi J, Sasako Y et al (2002) The impact of diabetic retinopathy on long-term outcome following coronary artery bypass graft surgery. J Am Coll Cardiol 40:428–436PubMedCrossRef Ono T, Kobayashi J, Sasako Y et al (2002) The impact of diabetic retinopathy on long-term outcome following coronary artery bypass graft surgery. J Am Coll Cardiol 40:428–436PubMedCrossRef
26.
go back to reference Tong PC, Kong AP, So WY et al (2007) Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with type 2 diabetes mellitus. Diabet Med 24:741–746PubMedCrossRef Tong PC, Kong AP, So WY et al (2007) Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with type 2 diabetes mellitus. Diabet Med 24:741–746PubMedCrossRef
Metadata
Title
Proliferative retinopathy and proteinuria predict mortality rate in type 1 diabetic patients from Fyn County, Denmark
Authors
J. Grauslund
A. Green
A. K. Sjølie
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 4/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-0953-8

Other articles of this Issue 4/2008

Diabetologia 4/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.